argus

GlaxoSmithkline Pharmaceuticals Ltd.

NSE: GLAXOINE159A01016₹49,917 Cr

Timeline

Time (IST)TypeMEventSrc
12 Dec, 08:37 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updatesnse
12 Dec, 08:33 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30bse
19 Nov, 08:21 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updatesnse
19 Nov, 08:18 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30bse
10 Nov, 01:08 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript and Link of Recordingnse
10 Nov, 01:05 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
06 Nov, 09:37 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
06 Nov, 09:30 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
06 Nov, 04:47 pm—…Press Releasense
06 Nov, 04:37 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Acquisitionbse
06 Nov, 04:36 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updatesnse
06 Nov, 04:34 pm—…Outcome of meetingnse
06 Nov, 04:29 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Results Ended Quater September 2025bse
06 Nov, 04:25 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
06 Nov, 04:13 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
06 Nov, 04:12 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 06, 2025.nse
29 Oct, 12:50 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Managementnse
29 Oct, 12:46 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Managementbse
27 Oct, 02:26 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter & Half Year Ended 30Th September 2025.bse
08 Sept, 05:36 pm—…GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updatesnse
08 Sept, 05:31 pm—…GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30bse